Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. MU
2. QCOM
3. SPY
4. ICLR
5. JPM
6. USO
7. LAES
8. FUL
9. IBM
10. NNE

Go back to Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04
(NASDAQ: ADIL) Delayed: 2.54 +0.06 (2.42%)
Previous Close $2.48    52 Week High $ 
Open $2.45    52 Week Low $ 
Day High $2.58    P/E N/A 
Day Low $2.44    EPS $ 
Volume 71,200